Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu
URMC / Clinical & Translational Science Institute / Stories / May 2020 / Facing the Future: Team Science and Funding for Coronavirus Research

Facing the Future: Team Science and Funding for Coronavirus Research

The coronavirus pandemic has caused a number of government and private organizations to expand research funding in hopes of accelerating development of treatments and vaccines for coronavirus, and to learn more about the impact of COVID-19 on disease, well-being, and clinical practice.

Investigators across URMC have the opportunity to participate in a series of conversations about funding opportunities in sessions hosted by the UR Clinical and Translational Science Institute and its Center for Leading Innovation and Collaboration. These collaborative sessions are designed for researchers who are actively pursuing COVID-19-related grants and who would like to identify opportunities for synergy and collaboration among investigators, or receive feedback on the most relevant RFAs from funding sources such as NIH, AHRQ, DoD, PCORI and private foundations.

Because of the need for physical distancing, the sessions will be held on the Zoom meeting platform, and breakout rooms may be used to address specific topic areas.

Who should attend: URMC investigators planning to submit COVID-19-related grant proposals

Dates: May 11 – May 14, 2020

Time: 5:00 – 6:30 pm

Registration: Register for the individual session or sessions that correspond to your research.

Fees: No cost for registration

Objectives:

  • Bring together researchers who are actively pursuing COVID-19 related grants
  • Provide a discussion forum to identify opportunities for synergy and collaboration,
  • Receive feedback on or identify most relevant RFAs.

Important Note: Those attending a session should be prepared to give a 1-2 minute overview of the scope of their proposal.

Topics and Dates:

##

These events are supported by the University of Rochester CTSA award number UL1 TR002001 and the Center for Leading Innovation and Collaboration grant number U24TR002260 from the National Center for Advancing Translational Sciences of the National Institutes of Health.

Susanne Pritchard Pallo | 5/1/2020

You may also like